Amgen Executive Sells Stock Amid Company's Strong Earnings

Nancy Grygiel, Senior Vice President and Chief Compliance Officer at Amgen Inc. (), sold shares totaling approximately $1,194,415 on August 6, 2026, at a price of $402.1601 per share.

The dispositions were linked to the exercise of non-qualified stock options, through which Grygiel acquired shares valued at approximately $526,906, with prices ranging from $177.31 to $177.46 per share.

The transaction comes as Amgen shares trade near their 52-week high of $418.40, having delivered a 49% return over the past year.

Nancy Grygiel directly holds 7,340 shares of Amgen common stock.